114 related articles for article (PubMed ID: 17373929)
1. COX-2 promoter region polymorphisms in multiple sclerosis: lack of association of -765G>C with disease risk.
Mazzola S; Lira MG; Benedetti MD; Salviati A; Ottaviani S; Malerba G; Ortombina M; Pignatti PF
Int J Immunogenet; 2007 Apr; 34(2):71-4. PubMed ID: 17373929
[TBL] [Abstract][Full Text] [Related]
2. Association of functional gene variants in the regulatory regions of COX-2 gene (PTGS2) with nonmelanoma skin cancer after organ transplantation.
Lira MG; Mazzola S; Tessari G; Malerba G; Ortombina M; Naldi L; Remuzzi G; Boschiero L; Forni A; Rugiu C; Piaserico S; Girolomoni G; Turco A
Br J Dermatol; 2007 Jul; 157(1):49-57. PubMed ID: 17578436
[TBL] [Abstract][Full Text] [Related]
3. [Genetic polymorphisms in the promoter region of cyclooxygenase-2 and their association with risk of gastric cancer].
Zhang XM; Miao XP; Tan W; Sun T; Guo YL; Zhao D; Lin DX
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Apr; 28(2):119-23. PubMed ID: 16733888
[TBL] [Abstract][Full Text] [Related]
4. The COX-2 G/C -765 polymorphism may modulate the occurrence of cerebrovascular ischemia.
Colaizzo D; Fofi L; Tiscia G; Guglielmi R; Cocomazzi N; Prencipe M; Margaglione M; Toni D
Blood Coagul Fibrinolysis; 2006 Mar; 17(2):93-6. PubMed ID: 16479190
[TBL] [Abstract][Full Text] [Related]
5. [Association between single nucleotide polymorphisms in the promoter of cyclooxygenase COX-2 gene and hereditary susceptibility to pancreatic cancer].
Xu DK; Zhang XM; Zhao P; Cai JC; Zhao D; Tan W; Guo YL; Lin DX
Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(28):1961-5. PubMed ID: 19062735
[TBL] [Abstract][Full Text] [Related]
6. Platelet 12-lipoxygenase Arg261Gln polymorphism: functional characterization and association with risk of esophageal squamous cell carcinoma in combination with COX-2 polymorphisms.
Guo Y; Zhang X; Tan W; Miao X; Sun T; Zhao D; Lin D
Pharmacogenet Genomics; 2007 Mar; 17(3):197-205. PubMed ID: 17460548
[TBL] [Abstract][Full Text] [Related]
7. Association between Synapsin III gene promoter polymorphisms and multiple sclerosis.
Liguori M; Cittadella R; Manna I; Valentino P; La Russa A; Serra P; Trojano M; Messina D; Ruscica F; Andreoli V; Romeo N; Livrea P; Quattrone A
J Neurol; 2004 Feb; 251(2):165-70. PubMed ID: 14991350
[TBL] [Abstract][Full Text] [Related]
8. Functional polymorphisms of cyclooxygenase-2 (COX-2) gene and risk for esophageal squmaous cell carcinoma.
Upadhyay R; Jain M; Kumar S; Ghoshal UC; Mittal B
Mutat Res; 2009 Apr; 663(1-2):52-9. PubMed ID: 19428370
[TBL] [Abstract][Full Text] [Related]
9. The genetic influence of the nonclassical MHC molecule HLA-G on multiple sclerosis.
Kroner A; Grimm A; Johannssen K; Mäurer M; Wiendl H
Hum Immunol; 2007 May; 68(5):422-5. PubMed ID: 17462509
[TBL] [Abstract][Full Text] [Related]
10. Polymorphisms of COX-2 -765G>C and p53 codon 72 and risks of oral squamous cell carcinoma in a Taiwan population.
Lin YC; Huang HI; Wang LH; Tsai CC; Lung O; Dai CY; Yu ML; Ho CK; Chen CH
Oral Oncol; 2008 Aug; 44(8):798-804. PubMed ID: 18234542
[TBL] [Abstract][Full Text] [Related]
11. FcRL3 and multiple sclerosis pathogenesis: role in autoimmunity?
Martínez A; Mas A; de Las Heras V; Bartolomé M; Arroyo R; Fernández-Arquero M; de la Concha EG; Urcelay E
J Neuroimmunol; 2007 Sep; 189(1-2):132-6. PubMed ID: 17617473
[TBL] [Abstract][Full Text] [Related]
12. The SH2D2A gene and susceptibility to multiple sclerosis.
Lorentzen AR; Smestad C; Lie BA; Oturai AB; Akesson E; Saarela J; Myhr KM; Vartdal F; Celius EG; Sørensen PS; Hillert J; Spurkland A; Harbo HF
J Neuroimmunol; 2008 Jul; 197(2):152-8. PubMed ID: 18554728
[TBL] [Abstract][Full Text] [Related]
13. Genetic association between polymorphisms in the BTG1 gene and multiple sclerosis.
Camiña-Tato M; Morcillo-Suárez C; Navarro A; Fernández M; Horga A; Montalban X; Comabella M
J Neuroimmunol; 2009 Aug; 213(1-2):142-7. PubMed ID: 19515430
[TBL] [Abstract][Full Text] [Related]
14. CASP-9: A susceptibility locus for multiple sclerosis in Italy.
Andreoli V; Trecroci F; La Russa A; Valentino P; Condino F; Latorre V; Nisticò R; Pirritano D; Del Giudice F; Canino M; Cittadella R; Quattrone A
J Neuroimmunol; 2009 May; 210(1-2):100-3. PubMed ID: 19359048
[TBL] [Abstract][Full Text] [Related]
15. The role of VLA4 polymorphisms in multiple sclerosis: an association study.
Andreoli V; Cittadella R; Valentino P; Condino F; La Russa A; Liguori M; Manna I; Spadafora P; Nisticò R; Pirritano D; Clodomiro A; Quattrone A
J Neuroimmunol; 2007 Sep; 189(1-2):125-8. PubMed ID: 17609118
[TBL] [Abstract][Full Text] [Related]
16. T-1237C polymorphism of TLR9 gene is not associated with multiple sclerosis in the Portuguese population.
Carvalho A; Santos M; Maciel P; Rodrigues F
Mult Scler; 2008 May; 14(4):550-2. PubMed ID: 18208876
[TBL] [Abstract][Full Text] [Related]
17. An association study of two functional promotor polymorphisms in the myeloperoxidase (MPO) gene in multiple sclerosis.
Lundmark F; Salter H; Hillert J
Mult Scler; 2007 Jul; 13(6):697-700. PubMed ID: 17613595
[TBL] [Abstract][Full Text] [Related]
18. No evidence for association of CTLA-4 gene polymorphisms with the risk of developing multiple sclerosis: a meta-analysis.
Bagos PG; Karnaouri AC; Nikolopoulos GK; Hamodrakas SJ
Mult Scler; 2007 Mar; 13(2):156-68. PubMed ID: 17439880
[TBL] [Abstract][Full Text] [Related]
19. Association of MMP1, MMP3, MMP9, and MMP12 polymorphisms with risk and clinical course of multiple sclerosis in a Polish population.
Mirowska-Guzel D; Gromadzka G; Czlonkowski A; Czlonkowska A
J Neuroimmunol; 2009 Sep; 214(1-2):113-7. PubMed ID: 19628284
[TBL] [Abstract][Full Text] [Related]
20. Functional prostaglandin-endoperoxide synthase 2 polymorphism predicts poor outcome in sarcoidosis.
Hill MR; Papafili A; Booth H; Lawson P; Hubner M; Beynon H; Read C; Lindahl G; Marshall RP; McAnulty RJ; Laurent GJ
Am J Respir Crit Care Med; 2006 Oct; 174(8):915-22. PubMed ID: 16840740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
